Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 3/2012

01.05.2012 | Laboratory Investigation

Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema

verfasst von: Kaoru Tamura, Toshiyuki Yokoyama, Nobuyuki Ebihara, Akira Murakami

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the pathogenesis of diffuse diabetic maculae edema (DME).

Methods

Internal limiting membrane (ILM) specimens were surgically peeled from 16 eyes of 15 patients with diffuse DME (diabetic retinopathy (DR) group) and from 12 eyes of 12 patients without diabetes (non-DR group). The specimens were then examined by light microscopy (LM), transmission electron microscopy (TEM), and immunohistochemistry.

Results

Examination by LM revealed numerous cells on the inner surface of the ILM specimens in the DR-group, among which five different cell types (glial cell, fibroblast-like cell, macrophages, neutrophils, and lymphocytes) were confirmed. Examination by TEM revealed that the thickness of the peeled ILMs in the DR group was significantly greater, and four types of cellular element (glial, fibroblast-like, macrophages, and lymphocytes) were confirmed on the surface of the vitreous side of the specimens. The existence of glial cells and macrophages was confirmed by immunohistochemistry.

Conclusions

In diffuse DME, the ILM is thickened and a variety of cellular elements, especially numerous kinds of inflammatory cell, adhere to the inner surface of the ILM. To attenuate diffuse DME, vitrectomy combined with ILM peeling to remove the inflammatory cells and the physical barrier might be effective.
Literatur
1.
Zurück zum Zitat Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–9.PubMed Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–9.PubMed
2.
Zurück zum Zitat Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258–60.PubMed Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258–60.PubMed
3.
Zurück zum Zitat Terasaki H, Kojima T, Niwa H, Piao C, Ueno S, Kondo M, et al. Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci. 2003;44:4465–72.PubMedCrossRef Terasaki H, Kojima T, Niwa H, Piao C, Ueno S, Kondo M, et al. Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci. 2003;44:4465–72.PubMedCrossRef
4.
Zurück zum Zitat Ikeda T, Sato K, Katano T, Hayashi Y. Improve visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina. 2000;20:220–2.PubMedCrossRef Ikeda T, Sato K, Katano T, Hayashi Y. Improve visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina. 2000;20:220–2.PubMedCrossRef
5.
Zurück zum Zitat Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132:369–77.PubMedCrossRef Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132:369–77.PubMedCrossRef
6.
Zurück zum Zitat Patel JI, Hykin PG, Schadt M, Luong VY, Fitzke F, Gregor Z. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina. 2006;26:5–13.PubMedCrossRef Patel JI, Hykin PG, Schadt M, Luong VY, Fitzke F, Gregor Z. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina. 2006;26:5–13.PubMedCrossRef
7.
Zurück zum Zitat Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina. 2008;28:410–9.PubMedCrossRef Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina. 2008;28:410–9.PubMedCrossRef
8.
Zurück zum Zitat Kim YM, Chung EJ, Byeon SH, Lee S, Kwon OH, Koh HJ. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Ophthalmologica. 2009;223:17–23.PubMedCrossRef Kim YM, Chung EJ, Byeon SH, Lee S, Kwon OH, Koh HJ. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Ophthalmologica. 2009;223:17–23.PubMedCrossRef
9.
Zurück zum Zitat Recchia FM, Ruby A, Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447–54.PubMedCrossRef Recchia FM, Ruby A, Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447–54.PubMedCrossRef
10.
Zurück zum Zitat Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243:20–5.PubMedCrossRef Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243:20–5.PubMedCrossRef
11.
Zurück zum Zitat Kumar A, Sinha S, Azad R, Sharama YR, Vohra R. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:360–8.PubMedCrossRef Kumar A, Sinha S, Azad R, Sharama YR, Vohra R. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:360–8.PubMedCrossRef
12.
Zurück zum Zitat Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Visual outcome of patient with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2004;242:273–8.PubMedCrossRef Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Visual outcome of patient with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol. 2004;242:273–8.PubMedCrossRef
13.
Zurück zum Zitat Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina. 2000;20:126–33.PubMedCrossRef Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina. 2000;20:126–33.PubMedCrossRef
14.
Zurück zum Zitat Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina. 2005;25:311–6.PubMedCrossRef Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina. 2005;25:311–6.PubMedCrossRef
15.
Zurück zum Zitat Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996;44:1469–79.PubMedCrossRef Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996;44:1469–79.PubMedCrossRef
16.
Zurück zum Zitat Kohno T, Sorgente N, Goodnight R, Ryan S. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 1987;28:515–21.PubMed Kohno T, Sorgente N, Goodnight R, Ryan S. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 1987;28:515–21.PubMed
17.
Zurück zum Zitat Heij EC, Dieudonne SC, Mooy CM, Diederen R, Liem A, Suylen R, et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol. 2005;140:1123–5.PubMedCrossRef Heij EC, Dieudonne SC, Mooy CM, Diederen R, Liem A, Suylen R, et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol. 2005;140:1123–5.PubMedCrossRef
18.
Zurück zum Zitat Fine BS. Limiting membranes of the sensory retina and pigment epithelium. An electron microscopic study. Arch Ophthalmol. 1961;66:847–60.PubMedCrossRef Fine BS. Limiting membranes of the sensory retina and pigment epithelium. An electron microscopic study. Arch Ophthalmol. 1961;66:847–60.PubMedCrossRef
19.
Zurück zum Zitat Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7.PubMedCrossRef Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7.PubMedCrossRef
20.
Zurück zum Zitat Suzuki Y, Nakazawa M, Suzuki K, Yamazaki H, Miyagawa Y. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol. 2011;55:256–63.PubMedCrossRef Suzuki Y, Nakazawa M, Suzuki K, Yamazaki H, Miyagawa Y. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol. 2011;55:256–63.PubMedCrossRef
21.
Zurück zum Zitat Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T, et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci. 2001;42:229–34.PubMed Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T, et al. Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci. 2001;42:229–34.PubMed
22.
Zurück zum Zitat Haritoglou C, Gandorfer A, Gass CA, Shaumberger M, Ulbig MW, Kampik A. The effect of indocyanine green on functional outcome of macular pucker surgery. Am J Ophthalmol. 2003;135:328–37.PubMedCrossRef Haritoglou C, Gandorfer A, Gass CA, Shaumberger M, Ulbig MW, Kampik A. The effect of indocyanine green on functional outcome of macular pucker surgery. Am J Ophthalmol. 2003;135:328–37.PubMedCrossRef
23.
Zurück zum Zitat Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol. 2002;134:661–6.PubMedCrossRef Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A. Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol. 2002;134:661–6.PubMedCrossRef
24.
Zurück zum Zitat Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol. 2004;137:609–14.PubMed Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol. 2004;137:609–14.PubMed
25.
Zurück zum Zitat Gandorfer A, Haritoglou C, Gass CA, Ulbig W, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001;132:431–3.PubMedCrossRef Gandorfer A, Haritoglou C, Gass CA, Ulbig W, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001;132:431–3.PubMedCrossRef
26.
Zurück zum Zitat Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86:363–5.PubMedCrossRef Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86:363–5.PubMedCrossRef
27.
Zurück zum Zitat Kalvoda J, Duskova J, Kubena A, Povysul C, Kalvodova B. Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247:1307–14.PubMedCrossRef Kalvoda J, Duskova J, Kubena A, Povysul C, Kalvodova B. Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247:1307–14.PubMedCrossRef
Metadaten
Titel
Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema
verfasst von
Kaoru Tamura
Toshiyuki Yokoyama
Nobuyuki Ebihara
Akira Murakami
Publikationsdatum
01.05.2012
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 3/2012
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-012-0130-y

Weitere Artikel der Ausgabe 3/2012

Japanese Journal of Ophthalmology 3/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.